Subcutaneous injections offer various benefits over IV infusions, including improved comfort, convenience, and ease of treatment. However, there is no one-size-fits-all approach to cancer treatment.

What if you could inject a drug into a "problem area" – like abdominal fat – that could kill off fat cells and reduce fat ...

Panelists discuss how challenges such as extended nursing workflow, patient hesitancy, limited formulation indications, ...

Mohammady M et al (2017) Slow versus fast subcutaneous heparin injections for prevention of bruising and site pain intensity. Cochrane Database of Systematic Reviews; 10: CD008077. Ogston-Tuck S (2014 ...

The prefilled, patient-ready-to-use system is said to support delivery of high-viscosity biologics of up to 50 centipoise.

Ocrevus subcutaneous injection was non-inferior to Ocrevus IV infusion as measured by Ocrevus levels in the blood of patients (area under the serum concentration time curve) from day 1 to 12 weeks ...

Further, pharmacokinetic modeling predicts that convenient dosing regimens of VRDN-003 (e.g., a low volume subcutaneous injection once every 4 or 8 weeks) could achieve exposure levels of VRDN-003 ...

A new kind of HIV prevention is making it easier for those at risk to stay protected, thanks to a twice-yearly injection now ...

OCARINA II randomized 236 MS patients to 920 mg subcutaneous injection (118 participants) or 600 mg IV infusion (118 participants). Infusions were administered at 300 mg at two IV sessions, 2 ...

FDA approves OCREVUS ZUNOVO™ as the first and only twice-a-year 10-minute subcutaneous injection for people with relapsing and progressive multiple sclerosis Published Sep 16, 2024 1:00am EDT ...

Argenx’s subcutaneous formulation of the active ingredient in Vyvgart has hit the primary endpoint in a phase 3 trial, clearing the biotech to file for approval of a product it expects to become ...